findmyKOL
Clinical trialNCT01389427CompletedPhase 1/PHASE2Interventional

Escalating Doses of Torisel in Combination With Three Chemotherapies Regimens: R-CHOP, R-FC or R-DHA for Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL).

SponsorThe Lymphoma Academic Research OrganisationEnrollment41Mantle Cell Lymphoma Refractory
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Chu de Grenoble Michallon

    Grenoble, Hôpital Nord 217, France

  • Hôtel Dieu - Université de Nantes

    Nantes, Place Alexis Ricordeau, France

  • Hôpital Henri Mondor

    Créteil, France

  • Chu de Dijon

    Dijon, France

  • Hôpital Saint-Eloi

    Montpellier, France

  • Hôpital Necker

    Paris, France

  • Hôpital Saint Louis

    Paris, France

  • Groupe Hospitalier Sud Hôpital Haut-Lévêque

    Pessac, France

  • Centre Hospitalier Lyon Sud

    Pierre-Bénite, France

  • Chu Pontchaillou

    Rennes, France

  • Chu de Tours - Hôpital Bretonneau

    Tours, France

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2011
Primary completion
31 May 2015
Completion
30 Sept 2015
Last update posted
9 Mar 2017
Registered enrollment
41
Registry id
NCT01389427
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.